Oramed Pharmaceuticals Inc. — Director's Dealing 2017

Apr 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2017-04-19

Reporting Person: Kidron Miriam (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-19	Common Stock	S	52814	$6.33	Disposed	89636	Direct

Footnotes

F1: These shares were sold to Li Xiapeng, a director of Oramed Pharmaceuticals Inc.

F2: Consists of 89,636 shares of Common Stock underlying vested Restricted Stock Units that are issuable upon request.